Values First Advisors’s Natus Medical Inc NTUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,769
Closed -$418K 164
2022
Q2
$418K Sell
12,769
-891
-7% -$28.2K 0.3% 94
2022
Q1
$359K Buy
13,660
+1,125
+9% +$27.5K 0.23% 115
2021
Q4
$297K Sell
12,535
-1,181
-9% -$29.1K 0.18% 130
2021
Q3
$344K Buy
13,716
+439
+3% +$11.2K 0.22% 118
2021
Q2
$345K Sell
13,277
-271
-2% -$7.37K 0.23% 122
2021
Q1
$347K Buy
13,548
+170
+1% +$4.36K 0.26% 117
2020
Q4
$268K Sell
13,378
-386
-3% -$7.56K 0.21% 127
2020
Q3
$236K Buy
13,764
+690
+5% +$13K 0.22% 125
2020
Q2
$285K Sell
13,074
-286
-2% -$6.55K 0.28% 106
2020
Q1
$309K Buy
13,360
+878
+7% +$25.5K 0.37% 84
2019
Q4
$412K Buy
+12,482
New +$400K 0.4% 84

Other funds holding NTUS

Values First Advisors's NTUS Position: Q3 2022 in Review

Values First Advisors sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 12,769 shares — an estimated $418K sold.

Values First Advisors first reported a position in NTUS in Q4 2019 and held it in 11 quarters. The position peaked at $418K in Q2 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.

  • Values First Advisors reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
  • Values First Advisors sold 12,769 Natus Medical Inc shares in Q3 2022, an estimated $418K.
  • Values First Advisors first reported a position in Natus Medical Inc in Q4 2019 and held it in 11 quarters.
  • Values First Advisors's Natus Medical Inc position peaked at $418K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.

Based on Values First Advisors's 13F filing for Q3 2022, filed 2 Dec 2022.